4Tech Takes On “The Forgotten Valve” With TriCinch Transcatheter Repair System
A $29m series B financing will allow 4Tech to complete a feasibility trial of its TriCinch transcatheter tricuspid valve repair system, according to the company.
A $29m series B financing will allow 4Tech to complete a feasibility trial of its TriCinch transcatheter tricuspid valve repair system, according to the company.